跳至主要内容
临床试验/NCT04873180
NCT04873180已完成不适用

A Retrospective Study

Sohag University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
expression of survivin in neoplastic and adjacent normal renal tissues

研究概览

简要总结

detection of Survivin expression in renal cell carcinoma and correlate this expression to tumor grade and stage.

详细描述

renal cell carcinoma is the third most prevalent malignant tumor of the genitourinary system. deregulation of apoptosis is involved in carcinogenesis by abnormally prolonged cell survival, facilitating accumulations of multiple mutations and augment resistance to immune-surveillance. Survivin is a member of inhibitor of Apoptosis Protein family (IAPs). it play a role in cell cycle regulation by inhibiting apiptosis. Survivin is over-expressed in many human neoplasms.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients suffer from renal cell carcinomas

排除标准

  • patients received pre-operative chemotherapy or radiotherapy. patients with insufficient clinical data.

结局指标

主要结局

expression of survivin in neoplastic and adjacent normal renal tissues

时间窗: april, 2021

Survivin is highly expressed in neoplastic renal tissues compared to normal ones by immunohistochemical measures..

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maisa Hashem Mohammed

lecturer of pathology

Sohag University

研究点 (1)

Loading locations...

相似试验